Invesco’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Invesco’s Portfolio OCEA Stock Details OCEA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-23,874	Closed	-$90.4K	–	3993
2024 Q1	$90.4K	Buy	+23,874	New	+$44.9K	﹤0.01%	3755

Other funds holding OCEA

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco's OCEA Position: Q2 2024 in Review

Invesco sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q2 2024, closing a stake of 23,874 shares — an estimated $90.4K sold.

Invesco first reported a position in OCEA in Q1 2024 and held it in 1 quarter. The position peaked at $90.4K in Q1 2024. 36 funds tracked by Wall St. Rank hold OCEA as of Q2 2024.

Invesco reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Invesco sold 23,874 Ocean Biomedical, Inc. Common Stock shares in Q2 2024, an estimated $90.4K.
Invesco first reported a position in Ocean Biomedical, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
Invesco's Ocean Biomedical, Inc. Common Stock position peaked at $90.4K in Q1 2024.
36 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q2 2024.

Based on Invesco's 13F filing for Q2 2024, filed 13 Aug 2024.